BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31509447)

  • 1. Statin administration activates system xC
    Rebalka IA; Cao AW; May LL; Tarnopolsky MA; Hawke TJ
    Am J Physiol Cell Physiol; 2019 Nov; 317(5):C894-C899. PubMed ID: 31509447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients experiencing statin-induced myalgia exhibit a unique program of skeletal muscle gene expression following statin re-challenge.
    Elam MB; Majumdar G; Mozhui K; Gerling IC; Vera SR; Fish-Trotter H; Williams RW; Childress RD; Raghow R
    PLoS One; 2017; 12(8):e0181308. PubMed ID: 28771594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin Treatment Decreases Mitochondrial Respiration But Muscle Coenzyme Q10 Levels Are Unaltered: The LIFESTAT Study.
    Dohlmann TL; Morville T; Kuhlman AB; Chrøis KM; Helge JW; Dela F; Larsen S
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2501-2508. PubMed ID: 30299473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins Trigger Mitochondrial Reactive Oxygen Species-Induced Apoptosis in Glycolytic Skeletal Muscle.
    Bouitbir J; Singh F; Charles AL; Schlagowski AI; Bonifacio A; Echaniz-Laguna A; Geny B; Krähenbühl S; Zoll J
    Antioxid Redox Signal; 2016 Jan; 24(2):84-98. PubMed ID: 26414931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic myositis-myalgia in hypercholesterolemic statin-treated patients with concurrent vitamin D deficiency leading to statin intolerance may reflect a reversible interaction between vitamin D deficiency and statins on skeletal muscle.
    Glueck CJ; Abuchaibe C; Wang P
    Med Hypotheses; 2011 Oct; 77(4):658-61. PubMed ID: 21802861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin therapy induces ultrastructural damage in skeletal muscle in patients without myalgia.
    Draeger A; Monastyrskaya K; Mohaupt M; Hoppeler H; Savolainen H; Allemann C; Babiychuk EB
    J Pathol; 2006 Sep; 210(1):94-102. PubMed ID: 16799920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle-related side-effects of statins: from mechanisms to evidence-based solutions.
    Taylor BA; Thompson PD
    Curr Opin Lipidol; 2015 Jun; 26(3):221-7. PubMed ID: 25943841
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in muscle strength in individuals with statin-induced myopathy: A summary of 3 investigations.
    Panza GA; Taylor BA; Dada MR; Thompson PD
    J Clin Lipidol; 2015; 9(3):351-6. PubMed ID: 26073393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geranylgeraniol Prevents Statin-Dependent Myotoxicity in C2C12 Muscle Cells through RAP1 GTPase Prenylation and Cytoprotective Autophagy.
    Jaśkiewicz A; Pająk B; Litwiniuk A; Urbańska K; Orzechowski A
    Oxid Med Cell Longev; 2018; 2018():6463807. PubMed ID: 29951166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized trial of coenzyme Q10 in patients with confirmed statin myopathy.
    Taylor BA; Lorson L; White CM; Thompson PD
    Atherosclerosis; 2015 Feb; 238(2):329-35. PubMed ID: 25545331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human skeletal muscle drug transporters determine local exposure and toxicity of statins.
    Knauer MJ; Urquhart BL; Meyer zu Schwabedissen HE; Schwarz UI; Lemke CJ; Leake BF; Kim RB; Tirona RG
    Circ Res; 2010 Feb; 106(2):297-306. PubMed ID: 19940267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin-associated muscle injury.
    Ballard KD; Taylor BA; Thompson PD
    Eur J Prev Cardiol; 2015 Sep; 22(9):1161. PubMed ID: 25948131
    [No Abstract]   [Full Text] [Related]  

  • 13. Changes in muscle strength in patients with statin myalgia.
    Panza GA; Taylor BA; Roman W; Thompson PD
    Am J Cardiol; 2014 Oct; 114(8):1215-6. PubMed ID: 25171803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional effects of TrkA inhibition on system x
    Miladinovic T; Ungard RG; Linher-Melville K; Popovic S; Singh G
    Mol Pain; 2018; 14():1744806918776467. PubMed ID: 29761734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PGC-1β modulates statin-associated myotoxicity in mice.
    Singh F; Zoll J; Duthaler U; Charles AL; Panajatovic MV; Laverny G; McWilliams TG; Metzger D; Geny B; Krähenbühl S; Bouitbir J
    Arch Toxicol; 2019 Feb; 93(2):487-504. PubMed ID: 30511338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of statins on distinct circulating microRNAs during prolonged aerobic exercise.
    Min PK; Park J; Isaacs S; Taylor BA; Thompson PD; Troyanos C; D'Hemecourt P; Dyer S; Chan SY; Baggish AL
    J Appl Physiol (1985); 2016 Mar; 120(6):711-20. PubMed ID: 26472872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitophagy protects against statin-mediated skeletal muscle toxicity.
    Ramesh M; Campos JC; Lee P; Song Y; Hernandez G; Sin J; Tucker KC; Saadaeijahromi H; Gurney M; Ferreira JCB; Andres AM
    FASEB J; 2019 Nov; 33(11):11857-11869. PubMed ID: 31365836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic Exercise Performance and Muscle Strength in Statin Users-The LIFESTAT Study.
    Morville T; Dohlmann TL; Kuhlman AB; Sahl RE; Kriegbaum M; Larsen S; Dela F; Helge JW
    Med Sci Sports Exerc; 2019 Jul; 51(7):1429-1437. PubMed ID: 31210648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of HMG-CoA reductase inhibitors on skeletal muscle: are all statins the same?
    Evans M; Rees A
    Drug Saf; 2002; 25(9):649-63. PubMed ID: 12137559
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.